United States · FDA National Drug Code directory
Naloxone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-1219_f1e72697-b477-4007-a9c0-d572576117fe
- Product NDC
- 0409-1219
- Form
- INJECTION, SOLUTION
- Composition / generic term
- NALOXONE HYDROCHLORIDE
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050902
- Source listing expiry
- 20271231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — .4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 CARTON in 1 CASE (0409-1219-01) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE (0409-1219-41) · 0409-1219-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →